U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from Books

Items: 12

1.
Impact of non‐adherence on the safety and efficacy of uric acid‐lowering therapies in the treatment of gout
Daniel Hill‐McManus, Elena Soto, Scott Marshall, Steven Lane, Dyfrig Hughes
Br J Clin Pharmacol. 2018 Jan; 84(1): 142–152. Published online 2017 Oct 10. doi: 10.1111/bcp.13427
Correction in:
Br J Clin Pharmacol. 2019 Aug; 85(8): 1865.
PMCID:
PMC5736842
ArticlePDF–979K
2.
Treatment Options for Gout
Bettina Engel, Johannes Just, Markus Bleckwenn, Klaus Weckbecker
Dtsch Arztebl Int. 2017 Mar; 114(13): 215–222. Published online 2017 Mar 31. doi: 10.3238/arztebl.2017.0215
PMCID:
PMC5624445
ArticlePDF–470K
3.
Lesinurad in combination with allopurinol: a randomised, double-blind, placebo-controlled study in patients with gout with inadequate response to standard of care (the multinational CLEAR 2 study)
Thomas Bardin, Robert T Keenan, Puja P Khanna, Jeff Kopicko, Maple Fung, Nihar Bhakta, Scott Adler, Chris Storgard, Scott Baumgartner, Alexander So
Ann Rheum Dis. 2017 May; 76(5): 811–820. Published online 2016 Nov 7. doi: 10.1136/annrheumdis-2016-209213
PMCID:
PMC5530336
ArticlePDF–1.0M
4.
Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC®) for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants: 2016 Update
J. Kevin Hicks, Katrin Sangkuhl, Jesse J. Swen, Vicki L. Ellingrod, Daniel J. Müller, Kazutaka Shimoda, Jeffrey R. Bishop, Evan D. Kharasch, Todd C. Skaar, Andrea Gaedigk, Henry M. Dunnenberger, Teri E. Klein, Kelly E. Caudle, Julia C. Stingl
Clin Pharmacol Ther. Author manuscript; available in PMC 2018 Jun 20.
Published in final edited form as: Clin Pharmacol Ther. 2017 Jul; 102(1): 37–44. Published online 2017 Feb 13. doi: 10.1002/cpt.597
PMCID:
PMC5478479
ArticlePDF–166K
5.
Lesinurad: A significant advancement or just another addition to existing therapies of gout?
Ajay Gupta, Pramod Kumar Sharma, Arup Kumar Misra, Surjit Singh
J Pharmacol Pharmacother. 2016 Oct-Dec; 7(4): 155–158. doi: 10.4103/0976-500X.195897
PMCID:
PMC5242027
ArticlePDF–408K
6.
The epidemiology and treatment of gout
Neil W McGill
Open Access Rheumatol. 2011; 3: 73–82. Published online 2011 Dec 20. doi: 10.2147/OARRR.S10313
PMCID:
PMC5074782
ArticlePDF–180K
7.
Lesinurad, a novel, oral compound for gout, acts to decrease serum uric acid through inhibition of urate transporters in the kidney
Jeffrey Miner, Philip K. Tan, David Hyndman, Sha Liu, Cory Iverson, Payal Nanavati, David T. Hagerty, Kimberly Manhard, Zancong Shen, Jean-Luc Girardet, Li-Tain Yeh, Robert Terkeltaub, Barry Quart
Arthritis Res Ther. 2016; 18: 214. Published online 2016 Oct 3. doi: 10.1186/s13075-016-1107-x
Correction in:
Arthritis Res Ther. 2016; 18: 236.
PMCID:
PMC5048659
ArticlePDF–991K
8.
Pharmacogenetic Allele Nomenclature: International Workgroup Recommendations for Test Result Reporting
Lisa V. Kalman, José A.G. Agúndez, Malin Lindqvist Appell, John Logan Black, Gillian C. Bell, Sotiria Boukouvala, Carsten Bruckner, Elspeth Bruford, Carsten Bruckner, Kelly Caudle, Sally Coulthard, Ann K. Daly, Andria L. Del Tredici, Johan T den Dunnen, Katarzyna Drozda, Robin Everts, David Flockhart, Robert Freimuth, Andrea Gaedigk, Houda Hachad, Toinette Hartshorne, Magnus Ingelman-Sundberg, Teri E. Klein, Volker M. Lauschke, Donna R. Maglott, Howard L. McLeod, Gwendolyn A. McMillin, Urs A. Meyer, Daniel J. Müller, Deborah A. Nickerson, William S. Oetting, Michael Pacanowski, Victoria M. Pratt, Mary V. Relling, Ali Roberts, Wendy S. Rubinstein, Katrin Sangkuhl, Matthias Schwab, Stuart A. Scott, Sarah C Sim, Ranjit K Thirumaran, Lorraine H. Toji, Rachel Tyndale, Ron HN van Schaik, Michelle Whirl-Carrillo, Kiang-Teck J Yeo, Ulrich M. Zanger
Clin Pharmacol Ther. Author manuscript; available in PMC 2017 Feb 1.
Published in final edited form as: Clin Pharmacol Ther. 2016 Feb; 99(2): 172–185. Published online 2015 Nov 20. doi: 10.1002/cpt.280
PMCID:
PMC4724253
ArticlePDF–673K
9.
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and HLA‐B Genotypes and Phenytoin Dosing
K E Caudle, A E Rettie, M Whirl‐Carrillo, L H Smith, S Mintzer, M T M Lee, T E Klein, J T Callaghan
Clin Pharmacol Ther. 2014 Nov; 96(5): 542–548. Published online 2014 Aug 6. doi: 10.1038/clpt.2014.159
PMCID:
PMC4206662
ArticlePDF–320K
10.
Epidemiology of Gout
Edward Roddy, Hyon Choi
Rheum Dis Clin North Am. Author manuscript; available in PMC 2015 May 1.
Published in final edited form as: Rheum Dis Clin North Am. 2014 May; 40(2): 155–175. Published online 2014 Feb 19. doi: 10.1016/j.rdc.2014.01.001
PMCID:
PMC4119792
ArticlePDF–522K
11.
Clinical Pharmacogenetics Implementation Consortium Guidelines for Human Leukocyte Antigen-B Genotype and Allopurinol Dosing
M S Hershfield, J T Callaghan, W Tassaneeyakul, T Mushiroda, C F Thorn, T E Klein, M T M Lee
Clin Pharmacol Ther. 2013 Feb; 93(2): 153–158. Prepublished online 2012 Oct 17. Published online 2012 Dec 12. doi: 10.1038/clpt.2012.209
PMCID:
PMC3564416
ArticlePDF–507K
12.
Body Mass Index, Obesity, and Prevalent Gout in the United States in 1988–1994 and 2007–2010
Stephen P. Juraschek, Edgar R. Miller, III, Allan C. Gelber
Arthritis Care Res (Hoboken) Author manuscript; available in PMC 2014 Jan 1.
Published in final edited form as: Arthritis Care Res (Hoboken). 2013 Jan; 65(1): 127–132. doi: 10.1002/acr.21791
PMCID:
PMC3482278
ArticlePDF–398K

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center